{
    "eid": "2-s2.0-85121405799",
    "title": "False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes",
    "cover-date": "2021-06-17",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "bacterial translocation",
        "inflammation",
        "neuroimmune",
        "oxidative and nitrosative stress pathways",
        "schizophrenia"
    ],
    "authors": [
        "Michael Maes",
        "George Anderson"
    ],
    "citedby-count": 7,
    "ref-count": 32,
    "ref-list": [
        "Could Alzheimer's disease originate in the periphery and if so, how so?",
        "Lowered antioxidant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: a nomothetic network psychiatry approach",
        "How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia",
        "How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry",
        "Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: a follow-up study",
        "Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review",
        "Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "Maternal immune activation causes schizophrenia-like behaviors in the offspring through activation of immune-inflammatory, oxidative and apoptotic pathways, and lowered antioxidant defenses and neuroprotection",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis",
        "The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Changes in Tryptophan Catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Positive vs. negative schizophrenia: a critical evaluation",
        "Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters",
        "Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: role of the aryl hydrocarbon receptor and direct mitochondria regulation",
        "The negative symptoms of schizophrenia: category or continuum?",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis",
        "Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia",
        "Pathway-phenotypes of non-responders and partial responders to treatment with antipsychotics in schizophrenia: a machine learning study",
        "Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, Klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode schizophrenia",
        "Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates",
        "The two-syndrome concept: origins and current status",
        "Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries",
        "The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia",
        "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
        "Definitions of response and remission in schizophrenia: recommendations for their use and their presentation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "London",
            "@id": "123412614",
            "affilname": "CRC Scotland &amp; London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123412614",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Ratchadapiseksompotch Funds",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}